                         SEQUENCE LISTING

<110>  Vasomune Therapeutics Inc.
       Sunnybrook Research Institute
 
<120>  AN AGENT FOR PROMOTING ANGIOGENESIS AND METHODS AND USES THEREOF

<130>  23632-P52201PC00

<150>  62/446,030
<151>  2017-01-13

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  1

His His His Arg His Ser Phe 
1               5           


<210>  2
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  2

Trp Thr Ile Ile Gln Arg Arg Glu Asp Gly Ser Val Asp Phe Gln Arg 
1               5                   10                  15      


Thr Trp Lys Glu Tyr Lys 
            20          


<210>  3
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  3

Asn Leu Leu Met Ala Ala Ser 
1               5           


<210>  4
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  4

Lys Leu Trp Val Ile Pro Lys 
1               5           


<210>  5
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  5

His Pro Trp Leu Thr Arg His 
1               5           


<210>  6
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  6

Cys His His His Arg His Ser Phe 
1               5               


<210>  7
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide


<220>
<221>  MISC_FEATURE
<223>  N-terminus has an MpA

<400>  7

His His His Arg His Ser Phe 
1               5           


